Tilray Brands Issues 1.6M Shares for Debt Exchange and Lyphe Acquisition
TLRY sits 47% above its 52-week low of $3.507.
Summary
Tilray Brands issued over 1.6 million common shares, primarily to convert $6 million in debt and as partial payment for the Lyphe Group acquisition, resulting in dilution for existing shareholders.
Key Events · Financing and Capital Events · TLRY
-
Debt-for-Equity Exchange
The company issued 1,214,186 shares of common stock on June 3, 2026, in exchange for $6 million aggregate principal amount of its 5.20% Convertible Senior Notes due June 15, 2027. This reduces debt but is dilutive.
-
Lyphe Group Acquisition Shares
On April 15, 2026, Tilray Brands issued 398,666 shares of common stock as partial consideration for the acquisition of the Lyphe Group.
-
Total Shares Issued
A combined total of 1,612,852 common shares were issued across both transactions, increasing the total outstanding shares.
Analysis · TLRY · Life Sciences
Tilray Brands issued a total of 1,612,852 common shares through two separate transactions. The larger portion, 1,214,186 shares, was part of a private debt-for-equity exchange, converting $6 million of convertible senior notes. This reduces the company's debt obligations but increases the outstanding share count. An additional 398,666 shares were issued as partial consideration for the acquisition of the Lyphe Group. These issuances represent a notable increase in share count, leading to dilution for existing shareholders, though the debt conversion improves the balance sheet.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1496 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TLRY was trading at $5.17 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $618.4M. The 52-week trading range was $3.51 to $23.20. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.